The Bright Promise of Stem Cell Research
Tags: STEM cells -- Research; EMBRYONIC stem cells; DISEASES; WOUNDS & injuries; PHARMACEUTICAL industry
Related Articles
- News in brief. // Nature Reviews Drug Discovery;Mar2012, Vol. 11 Issue 3, p177
The article offers news brief related to the U.S. pharmaceutical industry as of March 2012. It says that the U.S. Food and Drug Administration (FDA) has approved several landmark drugs for the treatment of specific diseases including Vertex's ivacaftor, Genentech's vismodegib, and Amylin's...
- Diabetes and cancer: A shared biological basis. // Biomedical Market Newsletter;9/30/2011, Vol. 21, p29
The article presents research suggesting the association of the biological basis of embryonic stem cell and cancer in mice.
- Scientists react to government indecision. Brown, Phyllida // Nature Medicine;Aug99, Vol. 5 Issue 8, p855
Discusses the government's delay in deciding whether to permit research into the therapeutic use of human embryonic stem cells in Great Britain. Creation of anti-science climate; Reaction of the researchers towards the delay.
- Japan okays stem cells. Saegusa, Asako // Nature Biotechnology;Mar2000, Vol. 18 Issue 3, p246
Reports on the approval given by the bioethics committee of Japan's Science and Technology Council for research involving the use of embryonic stem cells. Reason cited by the committee for granting approval to the research; Plans of the committee to draw up guidelines for embryonic stem cell...
- Change in Federal Stem Cell Funding Policy Spurs Interest in Field. Finkelstein, Joel B. // JNCI: Journal of the National Cancer Institute;5/6/2009, Vol. 101 Issue 9, p626
The article reports on the decision of U.S. President Barack Obama to reverse the Federal stem cell funding policy on March 9, 2009 in the U.S. It says that the president lifted the ban on the use of federal funds for human embryonic stem cells research. It further states that the scientists...
- 'CYBRID' STEM CELLS GET OK. // New Scientist;5/26/2007, Vol. 194 Issue 2605, p7
The article describes a technology that has been created to sidestep red tape surrounding the embryonic stem cell research issue. Scientists are now creating cybrids, which combine animal genes and cells with human embryos. This can create the same conditions as a purely human combination so...
- Adult Stem Cell Treatment for Spinal Cord Injury Shows Promise. Townsend, Liz // National Right to Life News;Aug2006, Vol. 33 Issue 8, p1
The article focuses on the findings of a study conducted by Doctor Carlos Lima that shows that a treatment that transplants patients' own nasal stem cells to the site of a spinal cord injury can renew the sensation and motor control of paralyzed patients. The study is being ignored by the media...
- First patient enters trial to test stem cells in spinal injury. Mayor, Susan // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;10/16/2010, Vol. 341 Issue 7777, p800
This article reports on the recruitment of the first patient in a clinical trial intended to assess the safety of oligodendrocyte progenitor cells derived from human embryonic stem cells in treating complete spinal cord injury, according to U.S. firm Geron. Particular focus is given to the...
- Court paints with broad brush, upends U.S. stem cell policy. Lefkowitz, Jay // Hill;9/16/2010, Vol. 17 Issue 100, p31
In this article the author focuses on the court ruling which emphasized the preclusion of an embryonic stem cell research project from receiving federal fundings by the Dickey-Wicker Amendment if one step of the project results in the destruction of an embryo in the U.S.
